Article ID Journal Published Year Pages File Type
5899350 Diabetes Research and Clinical Practice 2015 7 Pages PDF
Abstract

•Urinary albumin excretion increased with obesity stages.•Morbid obesity increases the risk of micro- and macroalbuminuria.•Adjusted glomerular filtration rate declined with obesity stages.•Morbid obesity interacts with type 2 diabetes to impair kidney function.

AimsType 2 diabetes and obesity impair kidney function. We examined their respective contributions to urinary albumin excretion (UAE) and glomerular filtration rate (GFR) in patients with type 2 diabetes and morbid obesity.MethodsCross-sectional, monocentric study of kidney function in patients with type 2 diabetes classified into four body mass index (BMI) stages: non-obese (<25 kg/m2, n = 157); overweight (25 to <30, n = 311); obesity (30 to <40, n = 310); and morbid obesity (≥40, n = 77), with 84 similarly staged controls without diabetes. UAE classes were defined as normal (<30 μg/mg creatinine), microalbuminuria (30-299), or macroalbuminuria (≥300) from 3 consecutive urine samples. GFR was measured by 51Cr EDTA plasma disappearance (adjusted and unadjusted to 1.73 m2 body surface area, as obesity increases body surface).ResultsParticipants with type 2 diabetes had same age, diabetes duration, and HbA1c across BMI stages. UAE was higher in participants with type 2 diabetes (p < 0.0001), and increased with obesity stages (p < 0.0001). After adjustment for age, sex, systolic blood pressure and type 2 diabetes status, morbid obesity was associated with a risk of microalbuminuria (OR 1.99, 95%CI 1.35-2.98, p = 0.0007) and macroalbuminuria (OR 2.33, 95%CI 1.25-4.22, p = 0.006). The body surface adjusted GFR was lower in patients with type 2 diabetes than in controls (p < 0.0001), and declined with obesity stages, contrary to controls. An interaction of diabetes and obesity was seen with unadjusted GFR values (p = 0.002).ConclusionsMorbid obesity interacts with type 2 diabetes to aggravate UAE and GFR. Treatment strategies should focus on both conditions to protect kidney function in these patients.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology
Authors
, , , , , , , , , , ,